+38 063 723 45 66 Monday-Friday 10:00-17:00
Item added
Cart
  • Your shopping cart is empty
Total 0₴

Buy Stendra in Ukraine

Sort By:
Stendra AVAFORCE 100 buy price reviews instructions
AVAFORCE 100
Stendra 100 mg
Number of tablets
560
Stendra AVAFORCE 200 buy price reviews instructions
AVAFORCE 200
Stendra 200 mg
Number of tablets
720
Stendra AVAFORCE 50 buy price reviews instructions
AVAFORCE 50
Stendra 50 mg
Number of tablets
400
Stendra AVANA 100 buy price reviews instructions
AVANA 100
Stendra 100 mg
Number of tablets
560
Stendra AVANA 200 buy price reviews instructions
AVANA 200
Stendra 200 mg
Number of tablets
720
Stendra AVANA 50 buy price reviews instructions
AVANA 50
Stendra 50 mg
Number of tablets
400
Stendra EXTRA SUPER AVANA buy price reviews instructions
EXTRA SUPER AVANA
Stendra + Dapoxetine
Number of tablets
880
Stendra SUPER AVANA buy price reviews instructions
SUPER AVANA
Stendra + Dapoxetine
Number of tablets
720
Stendra TOP AVANA buy price reviews instructions
TOP AVANA
Stendra + Dapoxetine
Number of tablets
560

What is SPEDRA (AVANAFIL)?

SPEDRA (AVANAFIL) is a modern pharmaceutical drug from the group of phosphodiesterase type 5 inhibitors, designed for the correction of erectile dysfunction in adult men. The active substance of the product is avanafil, which provides a rapid onset of action compared to many other representatives of this pharmacological group. The drug helps to improve blood supply to the cavernous bodies of the penis under the condition of sexual stimulation, which allows achieving and maintaining an erection sufficient for sexual intercourse. The release form is usually represented by tablets for oral administration with different dosages of the active substance. The product belongs to prescription drugs and is used only as prescribed by a doctor after evaluating the patient's health status.

The pharmacological group of SPEDRA (AVANAFIL) includes selective PDE-5 inhibitors used in urology and andrology for the symptomatic treatment of erectile dysfunction. Avanafil is characterized by high selectivity to the target enzyme, which potentially reduces the effect on other phosphodiesterase isoforms and associated undesirable effects. The drug does not increase libido on its own and does not work in the absence of sexual arousal, since its mechanism is linked to the physiological pathway of nitric oxide. Before starting therapy, it is important to undergo an examination to rule out cardiovascular and other contraindications. The individual response of the body to SPEDRA (AVANAFIL) may vary depending on age, concomitant diseases, and concomitant therapy.

In clinical practice, SPEDRA (AVANAFIL) is considered a relatively fast-acting drug, which is convenient for patients who require flexible planning of intimacy. Tablets should be stored in accordance with the manufacturer's instructions, out of reach of children, protected from moisture and excessive heat. Self-medication with this agent is unacceptable, as erectile dysfunction is often a marker of serious vascular or endocrine disorders. Consultation with a doctor before taking SPEDRA (AVANAFIL) is a prerequisite for safe use. Only a specialist can assess the benefit-risk ratio and select the optimal treatment regimen.

What is SPEDRA (AVANAFIL) prescribed for?

The main indication for the use of SPEDRA (AVANAFIL) is erectile dysfunction — the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. This condition can be associated with vascular disorders, neurological factors, hormonal imbalance, psychogenic causes, or a combination of several factors. The drug helps to restore the physiological mechanism of erection in the presence of adequate sexual stimulation. The doctor evaluates the severity of symptoms, the duration of the problem, and the impact on the quality of life before prescribing. It is important to understand that SPEDRA (AVANAFIL) addresses the symptom but does not treat the root cause of the dysfunction without a comprehensive approach.

The product can be considered in patients with organic, psychogenic, or mixed forms of erectile dysfunction after ruling out absolute contraindications. In men with concomitant diabetes mellitus, arterial hypertension, or after certain surgical interventions, efficacy and tolerability are evaluated individually. SPEDRA (AVANAFIL) is not intended to increase potency in men without diagnosed erectile dysfunction. Also, the drug is not used for the treatment of other sexual disorders, particularly premature ejaculation, as monotherapy without appropriate indications. The decision on therapy is made by a doctor based on medical history, examination, and, if necessary, additional diagnostic tests.

Sometimes SPEDRA (AVANAFIL) is included in the patient management scheme along with lifestyle modifications: smoking cessation, weight control, physical activity correction, and psychological support. This approach increases the chances of a lasting improvement in sexual function. The drug does not replace the treatment of the underlying disease that could have caused the erectile dysfunction. Patients should inform their doctor about all symptoms related to the cardiovascular system, as sexual activity itself places a strain on the heart. Before taking SPEDRA (AVANAFIL), a consultation with a specialist is mandatory, and the body's reaction always remains individual.

Composition and active components of SPEDRA (AVANAFIL)

The active substance of SPEDRA (AVANAFIL) is avanafil — a selective inhibitor of the enzyme phosphodiesterase type 5. Under physiological conditions, sexual stimulation promotes the release of nitric oxide in the cavernous tissue, which increases the level of cyclic guanosine monophosphate and relaxes the smooth muscles of the vessels. PDE-5 breaks down cGMP, so its blockade by avanafil prolongs and enhances this effect, improving blood flow to the penis. Due to its selectivity, avanafil has less effect on other isoforms of the enzyme, which is important for the safety profile. The dosage of the active substance in tablets is usually 50 mg, 100 mg, or 200 mg depending on the drug form.

The composition of SPEDRA (AVANAFIL) tablets also includes excipients that ensure the stability, disintegration, and absorption of the drug. These may include fillers, disintegrants, binders, film-coating agents, and other auxiliary ingredients according to the manufacturer's technology. These substances do not have an independent therapeutic effect in erectile dysfunction, but they are important for the quality of the dosage form. Patients with known hypersensitivity to any component should carefully study the composition before use. The exact list of excipients is specified in the official instructions for the specific package.

The mechanism of action of SPEDRA (AVANAFIL) is realized only under the condition of activation of the NO-cGMP pathway, that is, in the presence of sexual excitement. The drug does not cause a spontaneous erection "on demand" without stimulation. After administration, avanafil is absorbed relatively quickly, which explains the convenience of use shortly before the expected intimacy. Metabolism occurs mainly in the liver with the participation of the cytochrome system, so interaction with inducers and inhibitors of these enzymes is of clinical importance. Any changes in composition or dosage without agreement with a doctor are unacceptable.

Dosage of SPEDRA (AVANAFIL)

The recommended starting dose of SPEDRA (AVANAFIL) for most adult men is often 100 mg, taken approximately 15–30 minutes before expected sexual activity. Depending on efficacy and tolerability, the doctor may decrease the dose to 50 mg or increase it to the maximum recommended dose of 200 mg. The drug is used no more than once a day to avoid accumulation of effects and reduction of safety. The duration of the course is determined individually: the agent can be used episodically as needed or according to a regimen agreed with the doctor. Independent exceeding of the dose is strictly prohibited.

Dose adjustment of SPEDRA (AVANAFIL) is required for patients with mild to moderate hepatic or renal impairment, as well as individuals taking certain concomitant medications. In elderly men, pharmacokinetics may change, so the dose selection is carried out carefully, starting with lower values at the doctor's discretion. In severe hepatic or renal insufficiency, use is often restricted or excluded. Patients receiving moderate CYP3A4 inhibitors usually require a reduction in the maximum dose. All changes in the dose regimen are agreed only with the doctor.

The efficacy of the selected dose of SPEDRA (AVANAFIL) is evaluated over several attempts of use under conditions of adequate stimulation and in the absence of gross errors in administration. If the expected result is not achieved, you should not immediately increase the dose on your own — a repeat consultation is required. Sometimes the lack of effect is associated with incorrect timing of administration, alcohol consumption, or psychogenic factors. The maximum daily dose must not exceed the limit established in the instructions. The individual response of the body to SPEDRA (AVANAFIL) varies, so there is no universal "ideal" dose for everyone.

How to take SPEDRA (AVANAFIL) correctly?

SPEDRA (AVANAFIL) is taken orally, swallowed whole with a sufficient amount of water, without chewing. The optimal time of administration is approximately 15–30 minutes before planning sexual intercourse, although in some patients the action may develop in a different time window. Sexual stimulation remains a necessary condition for the realization of the drug's effect. It is not recommended to use the product along with excessively fatty food, which can potentially slow down absorption and delay the onset of action. Before the first intake, be sure to consult a doctor.

If a dose of SPEDRA (AVANAFIL) is missed at the planned moment, the next dose is taken only before the next expected activity, without doubling the number of tablets. The drug is not intended for daily "prophylactic" use without medical grounds, unless the doctor has determined a different regimen. It is important to maintain an interval of at least 24 hours between doses. During therapy, situations that create excessive cardiac load should be avoided if there are doubts about the state of the cardiovascular system. Any unusual sensations after administration require attention and, if necessary, seeking help.

Precautions regarding the intake of SPEDRA (AVANAFIL) include a ban on combining the agent with nitrates and nitric oxide donors. Patients are advised to inform all doctors they consult about the use of a PDE-5 inhibitor. Do not pass the drug to other people, even with similar complaints. Store tablets in the original packaging, taking into account the temperature regime specified by the manufacturer. Remember: consultation with a doctor before taking SPEDRA (AVANAFIL) and taking into account the individual reaction of the body is the key to safe use.

Side effects of SPEDRA (AVANAFIL)

Like other PDE-5 inhibitors, SPEDRA (AVANAFIL) can cause side effects, the frequency of which depends on the dose and individual characteristics. Common reactions include headache, flushing of the face, nasal congestion, dyspepsia, and dizziness. These phenomena are usually mild or moderate in nature and resolve on their own. Sometimes back pain or muscle discomfort is noted. If symptoms worsen or persist, you should consult a doctor, without continuing the intake "by force."

Uncommon and rarer side effects of SPEDRA (AVANAFIL) may include visual disturbances, palpitations, increased blood pressure or, conversely, hypotensive reactions, skin rashes, and edema. Very rarely, priapism is described — a prolonged, painful erection lasting more than 4 hours, which requires urgent medical attention due to the risk of tissue damage. Sudden hearing or vision loss is also possible, which is a reason to immediately stop use and seek help. Allergic reactions of varying severity occur infrequently, but require alertness. Any severe or unusual symptom after intake is a signal to consult a doctor.

The risk of side effects of SPEDRA (AVANAFIL) increases when exceeding the dose, combining with alcohol, nitrates, or potent inhibitors of metabolism. Patients with underlying vascular and heart diseases may tolerate even standard doses worse. It is important to keep a diary of well-being at the beginning of therapy and report all changes to the doctor. Self-prescription of symptomatic remedies "for side effects" without agreement is undesirable. The individual reaction of the body to SPEDRA (AVANAFIL) is not fully predictable, so medical supervision remains mandatory.

Contraindications of SPEDRA (AVANAFIL)

Absolute contraindications to SPEDRA (AVANAFIL) are hypersensitivity to avanafil or any component of the tablet, simultaneous administration of organic nitrates and nitric oxide donors, as well as the use of guanylate cyclase stimulators. The drug is not prescribed in conditions where sexual activity is contraindicated for cardiological reasons: unstable angina, severe arrhythmias, recent myocardial infarction, or stroke in the acute period according to the doctor's assessment. Severe hypotension, uncontrolled arterial hypertension, and certain forms of heart failure also restrict use. The decision on the safety of sexual activity is made by a cardiologist or therapist together with a urologist.

Relative contraindications and situations of increased caution include anatomical deformations of the penis, diseases predisposing to priapism, blood clotting disorders, active peptic ulcer disease, moderate hepatic and renal insufficiency. SPEDRA (AVANAFIL) is not intended for use in women, during pregnancy and lactation, as the indications apply only to male erectile dysfunction. The drug is contraindicated in children and adolescents. In elderly patients, a more thorough assessment of concomitant pathology and medication load is required.

Before prescribing SPEDRA (AVANAFIL), the doctor collects a complete medical history, clarifies the intake of alpha-blockers, antihypertensive drugs, and antifungal or antiretroviral drugs. In patients with hereditary degenerative diseases of the retina, the use of PDE-5 inhibitors is usually not recommended. It is forbidden to combine several potency remedies at the same time without medical control. If contraindications are detected after the examination, alternative correction methods are selected. Consultation with a doctor before taking SPEDRA (AVANAFIL) protects against dangerous complications, and the individual reaction of the body is always taken into account when choosing therapy.

Interaction of SPEDRA (AVANAFIL) with other drugs and alcohol

SPEDRA (AVANAFIL) has clinically significant interactions with drugs that affect vascular tone and metabolism in the liver. Simultaneous use with nitrates of any form can cause a sharp drop in blood pressure and is strictly prohibited. Potent CYP3A4 inhibitors, including certain azole antifungals, macrolides, and some antiretroviral drugs, increase the concentration of avanafil in the blood, which requires dose adjustment or refusal of the combination. Alpha-blockers and other antihypertensive drugs can enhance the hypotensive effect, so the combination is used only under the supervision of a doctor with possible separation in the time of administration. Before starting therapy, it is necessary to provide the doctor with a complete list of all medications and supplements.

Alcohol in significant quantities in combination with SPEDRA (AVANAFIL) increases the likelihood of dizziness, headache, tachycardia, and drop in blood pressure, as well as worsens the quality of erection. Moderate consumption of alcohol is still undesirable on the day of taking the drug. Regarding driving and operating machinery: if dizziness, visual disturbances, or decreased concentration occur, you should refrain from driving until the symptoms disappear completely. Patients are advised to evaluate their individual reaction to the first doses in safe conditions. The safety of combination therapy and lifestyle is always agreed with the doctor, as the body's reaction to SPEDRA (AVANAFIL) is individual.

Where to buy SPEDRA (AVANAFIL) in Ukraine

SPEDRA (AVANAFIL) in Ukraine is sold through pharmacy chains by doctor's prescription, and may also be available for order in licensed online pharmacies in compliance with the rules for dispensing prescription drugs. Before purchasing, it is necessary to obtain a consultation and a prescription to avoid the risks of counterfeits and incorrect self-prescription. Storage conditions require a dry place at the temperature specified in the instructions, without access to direct sunlight and moisture. Delivery of pharmacy orders is carried out in accordance with the internal rules of the establishment and the requirements for the transportation of medicines. When comparing offers, pay attention to the integrity of the packaging, expiration date, and the presence of instructions in Ukrainian.

When buying SPEDRA (AVANAFIL), the patient must remember that efficacy and safety depend not only on the quality of the drug, but also on proper medical supervision. You should not rely solely on advertising promises or reviews without an in-person assessment of your health status. If you have doubts about the originality of the packaging or contents, contact the pharmacist and doctor. Keep the receipt and information about the batch of the drug. Be sure to consult a doctor before taking SPEDRA (AVANAFIL): only a specialist will determine the feasibility of therapy, and the individual reaction of the body may differ even with the same dosage.

Free delivery from UAH 1000

Across Ukraine

Featured

Order with delivery

Self-medication can be dangerous to your health. Consult a doctor before using this medication..